Allison C. Crawley

1.3k total citations
24 papers, 1.0k citations indexed

About

Allison C. Crawley is a scholar working on Physiology, Epidemiology and Rheumatology. According to data from OpenAlex, Allison C. Crawley has authored 24 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Physiology, 7 papers in Epidemiology and 7 papers in Rheumatology. Recurrent topics in Allison C. Crawley's work include Lysosomal Storage Disorders Research (23 papers), Glycogen Storage Diseases and Myoclonus (7 papers) and Trypanosoma species research and implications (7 papers). Allison C. Crawley is often cited by papers focused on Lysosomal Storage Disorders Research (23 papers), Glycogen Storage Diseases and Myoclonus (7 papers) and Trypanosoma species research and implications (7 papers). Allison C. Crawley collaborates with scholars based in Australia, United States and New Zealand. Allison C. Crawley's co-authors include John J. Hopwood, Sharon Byers, Kim M. Hemsley, Barbara King, Vivienne Muller, Adeline A. Lau, Elizabeth Isaac, Gouri Yogalingam, Julie Bielicki and Maria Fuller and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Brain Research.

In The Last Decade

Allison C. Crawley

24 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Allison C. Crawley Australia 18 841 344 224 224 193 24 1.0k
Kia Langford‐Smith United Kingdom 14 702 0.8× 271 0.8× 219 1.0× 281 1.3× 87 0.5× 18 927
Lucie Vérot France 10 671 0.8× 195 0.6× 337 1.5× 219 1.0× 77 0.4× 11 1.0k
Ekaterina Zakharova Russia 16 439 0.5× 145 0.4× 311 1.4× 164 0.7× 119 0.6× 128 962
Mylvaganam Jeyakumar United Kingdom 18 1.4k 1.7× 483 1.4× 654 2.9× 609 2.7× 60 0.3× 23 1.8k
Paola Luzi United States 21 1.1k 1.3× 399 1.2× 626 2.8× 368 1.6× 24 0.1× 33 1.4k
Stefania Zampieri Italy 19 595 0.7× 126 0.4× 267 1.2× 183 0.8× 78 0.4× 34 867
Mercédes Pineda Spain 18 368 0.4× 127 0.4× 499 2.2× 82 0.4× 94 0.5× 29 1.0k
Wojciech Kaczmarski United States 20 530 0.6× 55 0.2× 348 1.6× 311 1.4× 65 0.3× 37 870
A. S. Najim Al-Din Kuwait 15 379 0.5× 316 0.9× 447 2.0× 201 0.9× 143 0.7× 27 1.7k
Hemanth R. Nelvagal United States 12 393 0.5× 252 0.7× 287 1.3× 260 1.2× 49 0.3× 23 733

Countries citing papers authored by Allison C. Crawley

Since Specialization
Citations

This map shows the geographic impact of Allison C. Crawley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allison C. Crawley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allison C. Crawley more than expected).

Fields of papers citing papers by Allison C. Crawley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Allison C. Crawley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allison C. Crawley. The network helps show where Allison C. Crawley may publish in the future.

Co-authorship network of co-authors of Allison C. Crawley

This figure shows the co-authorship network connecting the top 25 collaborators of Allison C. Crawley. A scholar is included among the top collaborators of Allison C. Crawley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Allison C. Crawley. Allison C. Crawley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Crawley, Allison C., Helen Beard, Sofia Hassiotis, et al.. (2011). Enzyme replacement reduces neuropathology in MPS IIIA dogs. Neurobiology of Disease. 43(2). 422–434. 43 indexed citations
2.
Hemsley, Kim M., Elizabeth J. Norman, Allison C. Crawley, et al.. (2009). Effect of cisternal sulfamidase delivery in MPS IIIA Huntaway dogs—A proof of principle study. Molecular Genetics and Metabolism. 98(4). 383–392. 48 indexed citations
3.
Hemsley, Kim M., Amanda Luck, Allison C. Crawley, et al.. (2009). Examination of intravenous and intra‐CSF protein delivery for treatment of neurological disease. European Journal of Neuroscience. 29(6). 1197–1214. 58 indexed citations
4.
Lau, Adeline A., Allison C. Crawley, John J. Hopwood, & Kim M. Hemsley. (2008). Open field locomotor activity and anxiety-related behaviors in mucopolysaccharidosis type IIIA mice. Behavioural Brain Research. 191(1). 130–136. 64 indexed citations
5.
Fraldi, Alessandro, Kim M. Hemsley, Allison C. Crawley, et al.. (2007). Functional correction of CNS lesions in an MPS-IIIA mouse model by intracerebral AAV-mediated delivery of sulfamidase and SUMF1 genes. Human Molecular Genetics. 16(22). 2693–2702. 103 indexed citations
6.
Crawley, Allison C., et al.. (2007). Behavioural characterisation of the α-mannosidosis guinea pig. Behavioural Brain Research. 186(2). 176–184. 7 indexed citations
7.
Crawley, Allison C., Briony L. Gliddon, Dyane Auclair, et al.. (2006). Characterization of a C57BL/6 congenic mouse strain of mucopolysaccharidosis type IIIA. Brain Research. 1104(1). 1–17. 85 indexed citations
8.
Crawley, Allison C., Barbara King, Thomas Berg, Peter J. Meikle, & Jeremy D. Hopwood. (2006). Enzyme replacement therapy in α-mannosidosis guinea-pigs. Molecular Genetics and Metabolism. 89(1-2). 48–57. 19 indexed citations
9.
Crawley, Allison C., et al.. (2005). Over-expression of human lysosomal α-mannosidase in mouse embryonic stem cells. Molecular Genetics and Metabolism. 85(3). 203–212. 5 indexed citations
10.
Meedeniya, Adrian Cuda Banda, et al.. (2005). Survival and engraftment of mouse embryonic stem cell-derived implants in the guinea pig brain. Neuroscience Research. 53(2). 161–168. 11 indexed citations
11.
Crawley, Allison C., Steven L. Ramsay, Sharon Byers, John J. Hopwood, & Peter J. Meikle. (2004). Monitoring Dose Response of Enzyme Replacement Therapy in Feline Mucopolysaccharidosis Type VI by Tandem Mass Spectrometry. Pediatric Research. 55(4). 585–591. 22 indexed citations
12.
Crawley, Allison C., et al.. (2003). Prevalence of Mucopolysaccharidosis Type VI Mutations in Siamese Cats. Journal of Veterinary Internal Medicine. 17(4). 495–498. 12 indexed citations
13.
Yogalingam, Gouri, Allison C. Crawley, John J. Hopwood, & Donald S. Anson. (1999). Evaluation of fibroblast-mediated gene therapy in a feline model of mucopolysaccharidosis type VI. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1453(2). 284–296. 11 indexed citations
14.
Bielicki, Julie, et al.. (1999). Advantages of Using Same Species Enzyme for Replacement Therapy in a Feline Model of Mucopolysaccharidosis Type VI. Journal of Biological Chemistry. 274(51). 36335–36343. 30 indexed citations
15.
Crawley, Allison C., et al.. (1999). α-Mannosidosis in the Guinea Pig: A New Animal Model for Lysosomal Storage Disorders. Pediatric Research. 46(5). 501–501. 33 indexed citations
16.
Crawley, Allison C., Gouri Yogalingam, Vivienne Muller, & John J. Hopwood. (1998). Two mutations within a feline mucopolysaccharidosis type VI colony cause three different clinical phenotypes.. Journal of Clinical Investigation. 101(1). 109–119. 44 indexed citations
17.
Yogalingam, Gouri, John J. Hopwood, Allison C. Crawley, & Donald S. Anson. (1998). Mild Feline Mucopolysaccharidosis Type VI. Journal of Biological Chemistry. 273(22). 13421–13429. 15 indexed citations
18.
Brooks, Doug A., Barbara King, Allison C. Crawley, Sharon Byers, & John J. Hopwood. (1997). Enzyme replacement therapy in Mucopolysaccharidosis VI: evidence for immune responses and altered efficacy of treatment in animal models. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1361(2). 203–216. 35 indexed citations
19.
Crawley, Allison C., et al.. (1997). Enzyme replacement therapy from birth in a feline model of mucopolysaccharidosis type VI.. Journal of Clinical Investigation. 99(4). 651–662. 108 indexed citations
20.
Yogalingam, Gouri, Tom Litjens, Julie Bielicki, et al.. (1996). Feline Mucopolysaccharidosis Type VI. Journal of Biological Chemistry. 271(44). 27259–27265. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kia Langford‐Smith Breakdown of academic impact, for papers by Lucie Vérot Breakdown of academic impact, for papers by Ekaterina Zakharova Breakdown of academic impact, for papers by Mylvaganam Jeyakumar Breakdown of academic impact, for papers by Paola Luzi Breakdown of academic impact, for papers by Stefania Zampieri Breakdown of academic impact, for papers by Mercédes Pineda Breakdown of academic impact, for papers by Wojciech Kaczmarski Breakdown of academic impact, for papers by A. S. Najim Al-Din Breakdown of academic impact, for papers by Hemanth R. Nelvagal
Rankless by CCL
2026